SynGap Missense Server

Table of SynGAP1 Isoform α2 (UniProt Q96PV0-1) Missense Variants.

c.dna Variant SGM Consensus Domain ClinVar gnomAD ESM1b AlphaMissense REVEL FoldX Rosetta Foldetta PremPS PROVEAN PolyPhen-2 HumDiv PolyPhen-2 HumVar FATHMM SIFT PAM Physical SASA Normalized B-factor backbone Normalized B-factor sidechain SynGAP Structural Annotation DOI
Clinical Status Review Subm. ID Allele count Allele freq. LLR score Prediction Pathogenicity Class Optimized Score Prediction Average ΔΔG Prediction StdDev ΔΔG Prediction ΔΔG Prediction ΔΔG Prediction Score Prediction pph2_prob Prediction pph2_prob Prediction Nervous System Score Prediction Prediction Status Conservation Sequences PAM250 PAM120 Hydropathy Δ MW Δ Average Δ Δ StdDev Δ StdDev Secondary Tertiary bonds Inside out GAP-Ras interface At membrane No effect MD Alert Verdict Description
c.2825C>TP942LLikely BenignUncertain 16-33443377-C-T42.48e-6-5.063Likely Benign0.086Likely BenignLikely Benign0.048Likely Benign-2.00Neutral0.411Benign0.239Benign2.37Pathogenic0.00Affected4.324-3-35.416.04
c.2408A>GK803RLikely BenignSH3-binding motifUncertain 1-2.281Likely Benign0.097Likely BenignLikely Benign0.018Likely Benign-1.52Neutral0.103Benign0.038Benign2.38Pathogenic0.00Affected3.77532-0.628.01
c.2369C>GT790SLikely BenignSH3-binding motifUncertain 1-3.914Likely Benign0.123Likely BenignLikely Benign0.134Likely Benign-1.83Neutral0.997Probably Damaging0.989Probably Damaging2.39Pathogenic0.33Tolerated3.64611-0.1-14.03
c.3026A>CE1009ALikely PathogenicUncertain 1-3.118Likely Benign0.679Likely PathogenicLikely Benign0.109Likely Benign-3.06Deleterious0.980Probably Damaging0.630Possibly Damaging2.39Pathogenic0.01Affected3.7750-15.3-58.04
c.3056G>AR1019HLikely BenignConflicting 26-33443608-G-A674.15e-5-4.610Likely Benign0.258Likely BenignLikely Benign0.122Likely Benign-1.95Neutral0.995Probably Damaging0.845Possibly Damaging2.39Pathogenic0.01Affected3.775201.3-19.05
c.3136C>GP1046ALikely BenignUncertain 16-33443688-C-G16.20e-7-3.246Likely Benign0.048Likely BenignLikely Benign0.041Likely Benign-1.67Neutral0.001Benign0.008Benign2.39Pathogenic0.29Tolerated3.775-113.4-26.04
c.3056G>TR1019LLikely PathogenicUncertain 16-33443608-G-T21.24e-6-5.194Likely Benign0.752Likely PathogenicLikely Benign0.110Likely Benign-3.57Deleterious0.800Possibly Damaging0.573Possibly Damaging2.40Pathogenic0.01Affected3.775-2-38.3-43.03
c.1786C>TR596C
(3D Viewer)
Likely PathogenicGAPConflicting 26-33440838-C-T63.72e-6-10.805Likely Pathogenic0.972Likely PathogenicLikely Pathogenic0.633Likely Pathogenic2.94Destabilizing0.01.49Ambiguous2.22Destabilizing-0.03Likely Benign-7.96Deleterious1.000Probably Damaging1.000Probably Damaging2.41Pathogenic0.00Affected3.3735-4-37.0-53.05230.797.9-0.10.0-0.30.4XXPotentially PathogenicThe guanidinium group of Arg596, located in an α helix (res. Glu582-Met603), forms a salt bridge with the carboxylate group of Glu495 from another α helix (res. Leu489-Glu519). In the WT simulations, the side chain of Arg596 hydrogen bonds with the backbone carbonyl groups of Asn487, Glu486, Arg485, and Phe484. Additionally, Arg596 can hydrogen bond with the carboxamide group of the Asn487 side chain on an opposing loop that links two α helices (res. Ala461-Arg475, res. Leu489-Glu519).In the variant simulations, the thiol group of the Cys596 side chain is unable to form salt bridges or any of the hydrogen bonds that the Arg596 side chain can. Thus, the residue swap could affect the tertiary structure assembly more profoundly than observed in the simulations. Notably, Arg596 plays a key role in positioning the aforementioned loop, which is crucial for the placement of the “arginine finger” or the Arg485 side chain during RasGTPase activation.
c.3307C>TR1103CUncertain 16-33443859-C-T63.92e-6-2.440Likely Benign0.246Likely BenignLikely Benign0.140Likely Benign-3.01Deleterious0.996Probably Damaging0.787Possibly Damaging2.41Pathogenic0.01Affected3.775-3-47.0-53.05
c.2420A>GY807CSH3-binding motifUncertain 16-33442972-A-G16.20e-7-7.228In-Between0.204Likely BenignLikely Benign0.243Likely Benign-3.89Deleterious0.997Probably Damaging0.934Probably Damaging2.42Pathogenic0.01Affected3.7750-23.8-60.04
c.3313C>TR1105WUncertain 16-33443865-C-T63.93e-6-6.911Likely Benign0.488AmbiguousLikely Benign0.133Likely Benign-4.34Deleterious0.999Probably Damaging0.696Possibly Damaging2.42Pathogenic0.02Affected3.775-323.630.03
c.1352T>CL451P
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-14.549Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.750Likely Pathogenic6.92Destabilizing0.28.57Destabilizing7.75Destabilizing2.58Destabilizing-6.81Deleterious1.000Probably Damaging1.000Probably Damaging2.43Pathogenic0.00Affected3.3734-3-3-5.4-16.04
c.1787G>AR596H
(3D Viewer)
Likely PathogenicGAPLikely Benign 16-33440839-G-A159.29e-6-11.128Likely Pathogenic0.950Likely PathogenicAmbiguous0.717Likely Pathogenic3.00Destabilizing0.90.43Likely Benign1.72Ambiguous1.35Destabilizing-4.97Deleterious1.000Probably Damaging0.999Probably Damaging2.43Pathogenic0.00Affected3.3735201.3-19.05223.580.5-0.10.0-0.10.3XXPotentially PathogenicThe guanidinium group of Arg596, located in an α helix (res. Glu582-Met603), forms a salt bridge with the carboxylate group of Glu495 from another α helix (res. Leu489-Glu519). In the WT simulations, the side chain of Arg596 hydrogen bonds with the backbone carbonyl groups of Asn487, Glu486, Arg485, and Phe484. Additionally, Arg596 can hydrogen bond with the carboxamide group of the Asn487 side chain on an opposing loop that links two α helices (res. Ala461-Arg475, res. Leu489-Glu519).In the variant simulations, the imidazole ring of His596 can form hydrogen bonds with the same residues as arginine; however, these interactions are not as coordinated or strong in comparison. Thus, the residue swap could affect the tertiary structure assembly more profoundly than observed in the simulations. Notably, Arg596 plays a key role in positioning the aforementioned loop, which is crucial for the placement of the “arginine finger” or the Arg485 side chain during RasGTPase activation.
c.1393C>GL465V
(3D Viewer)
Likely PathogenicGAPUncertain 1-9.893Likely Pathogenic0.838Likely PathogenicAmbiguous0.276Likely Benign2.46Destabilizing0.12.66Destabilizing2.56Destabilizing1.21Destabilizing-2.98Deleterious0.996Probably Damaging0.992Probably Damaging2.44Pathogenic0.10Tolerated3.3734210.4-14.03204.330.90.00.0-0.40.6XPotentially BenignThe iso-butyl side chain of Leu465, located in the middle of an α helix (res. Ala461–Phe476), packs with hydrophobic residues (e.g., Phe464, Met468, Tyr497, Ile494) in an inter-helix space formed with two other α helices (res. Ala461–Phe476 and res. Thr488-Gly502). In the variant simulations, the iso-propyl side chain of Val465 is equally sized and similarly hydrophobic as the original side chain of Leu465. Hence, the mutation does not exert any negative effects on the protein structure based on the variant simulations.
c.3308G>TR1103LLikely BenignUncertain 16-33443860-G-T-2.330Likely Benign0.205Likely BenignLikely Benign0.173Likely Benign-2.35Neutral0.002Benign0.005Benign2.44Pathogenic0.02Affected3.775-3-28.3-43.03
c.3323G>TS1108IUncertain 16-33443875-G-T-3.666Likely Benign0.292Likely BenignLikely Benign0.145Likely Benign-3.73Deleterious0.971Probably Damaging0.604Possibly Damaging2.44Pathogenic0.10Tolerated3.775-2-15.326.08
c.1787G>TR596L
(3D Viewer)
Likely PathogenicGAPUncertain 1-13.197Likely Pathogenic0.992Likely PathogenicLikely Pathogenic0.756Likely Pathogenic1.51Ambiguous0.3-0.58Ambiguous0.47Likely Benign-0.02Likely Benign-6.97Deleterious1.000Probably Damaging1.000Probably Damaging2.45Pathogenic0.00Affected3.3735-3-28.3-43.03234.263.4-0.10.0-0.50.6XXPotentially PathogenicThe guanidinium group of Arg596, located in an α helix (res. Glu582-Met603), forms a salt bridge with the carboxylate group of Glu495 from another α helix (res. Leu489-Glu519). In the WT simulations, the side chain of Arg596 hydrogen bonds with the backbone carbonyl groups of Asn487, Glu486, Arg485, and Phe484. Additionally, Arg596 can hydrogen bond with the carboxamide group of the Asn487 side chain on an opposing loop that links two α helices (res. Ala461-Arg475, res. Leu489-Glu519).However, in the variant simulations, the branched hydrocarbon side chain of Leu596 cannot form any of the hydrogen bonds or salt bridges maintained by the considerably bulkier and positively charged Arg596 side chain. Instead, Leu596 packs hydrophobically with the phenyl ring of Phe484 in the linker loop or residues from the opposing helix (e.g., Ile494, Thr491).Thus, the residue swap could affect the tertiary structure assembly more profoundly than observed in the simulations. Notably, Arg596 plays a key role in positioning the aforementioned loop, which is crucial for the placement of the “arginine finger” or the Arg485 side chain during RasGTPase activation.10.1016/j.ajhg.2020.11.011
c.2591C>TA864VLikely BenignUncertain 26-33443143-C-T63.72e-6-4.749Likely Benign0.126Likely BenignLikely Benign0.038Likely Benign-1.35Neutral0.767Possibly Damaging0.119Benign2.45Pathogenic0.30Tolerated3.824002.428.05
c.2960A>GD987GLikely PathogenicUncertain 1-4.782Likely Benign0.849Likely PathogenicAmbiguous0.234Likely Benign-2.79Deleterious0.943Possibly Damaging0.808Possibly Damaging2.45Pathogenic0.07Tolerated4.3221-13.1-58.04
c.3640C>TR1214WLikely PathogenicCoiled-coilUncertain 16-33446632-C-T21.24e-6-8.799Likely Pathogenic0.710Likely PathogenicLikely Benign0.143Likely Benign-4.95Deleterious1.000Probably Damaging0.983Probably Damaging2.45Pathogenic0.00Affected3.7752-33.630.03
c.2359C>AP787TLikely PathogenicSH3-binding motifLikely Benign 16-33442911-C-A171.05e-5-4.813Likely Benign0.603Likely PathogenicLikely Benign0.258Likely Benign-4.40Deleterious1.000Probably Damaging0.999Probably Damaging2.46Pathogenic0.01Affected3.6460-10.93.99
c.3059G>CR1020PLikely PathogenicUncertain 1-3.491Likely Benign0.902Likely PathogenicAmbiguous0.205Likely Benign-3.50Deleterious0.999Probably Damaging0.977Probably Damaging2.46Pathogenic0.00Affected0-22.9-59.07
c.3820C>TR1274CUncertain 16-33447868-C-T-6.467Likely Benign0.439AmbiguousLikely Benign0.170Likely Benign-5.22Deleterious1.000Probably Damaging0.996Probably Damaging2.46Pathogenic0.00Affected3.775-4-37.0-53.05
c.2216A>TE739VLikely BenignUncertain 1-3.136Likely Benign0.274Likely BenignLikely Benign0.085Likely Benign-1.86Neutral0.891Possibly Damaging0.575Possibly Damaging2.47Pathogenic0.00Affected4.322-2-27.7-29.98
c.3100C>GP1034ALikely BenignBenign 1-4.174Likely Benign0.178Likely BenignLikely Benign0.060Likely Benign-2.44Neutral0.059Benign0.061Benign2.47Pathogenic0.06Tolerated3.7751-13.4-26.04
c.2206C>TR736CConflicting 36-33441671-C-T84.96e-6-7.113In-Between0.120Likely BenignLikely Benign0.190Likely Benign-2.06Neutral0.999Probably Damaging0.825Possibly Damaging2.48Pathogenic0.00Affected4.073-4-37.0-53.05
c.2359C>TP787SSH3-binding motifUncertain 16-33442911-C-T31.86e-6-4.203Likely Benign0.564AmbiguousLikely Benign0.221Likely Benign-3.81Deleterious1.000Probably Damaging0.999Probably Damaging2.48Pathogenic0.02Affected3.646-110.8-10.04
c.3009C>GS1003RUncertain 1-5.113Likely Benign0.991Likely PathogenicLikely Pathogenic0.141Likely Benign-1.88Neutral0.999Probably Damaging0.996Probably Damaging2.48Pathogenic0.00Affected3.7750-1-3.769.11
c.2249G>AG750EUncertain 1-2.618Likely Benign0.413AmbiguousLikely Benign0.146Likely Benign-2.27Neutral1.000Probably Damaging0.982Probably Damaging2.49Pathogenic0.01Affected3.9950-2-3.172.06
c.3308G>AR1103HLikely BenignBenign/Likely benign 36-33443860-G-A312.03e-5-3.622Likely Benign0.156Likely BenignLikely Benign0.116Likely Benign-1.97Neutral0.996Probably Damaging0.733Possibly Damaging2.49Pathogenic0.01Affected3.775201.3-19.05
c.3821G>AR1274HLikely Benign 16-33447869-G-A42.58e-6-5.259Likely Benign0.256Likely BenignLikely Benign0.149Likely Benign-3.20Deleterious1.000Probably Damaging0.995Probably Damaging2.49Pathogenic0.01Affected3.775021.3-19.05
c.2207G>AR736HLikely BenignUncertain 16-33441672-G-A63.72e-6-5.409Likely Benign0.067Likely BenignLikely Benign0.029Likely Benign-0.12Neutral0.004Benign0.001Benign2.50Benign0.00Affected4.073201.3-19.05
c.3059G>TR1020LUncertain 1-6.031Likely Benign0.907Likely PathogenicAmbiguous0.216Likely Benign-4.03Deleterious0.990Probably Damaging0.921Probably Damaging2.50Benign0.00Affected3.775-3-28.3-43.03
c.3314G>AR1105QLikely BenignUncertain 26-33443866-G-A31.96e-6-3.666Likely Benign0.216Likely BenignLikely Benign0.104Likely Benign-1.21Neutral0.958Probably Damaging0.194Benign2.50Benign0.16Tolerated3.775111.0-28.06
c.3661C>TR1221WLikely PathogenicCoiled-coilConflicting 36-33446653-C-T16.20e-7-10.938Likely Pathogenic0.651Likely PathogenicLikely Benign0.174Likely Benign-4.57Deleterious1.000Probably Damaging0.987Probably Damaging2.50Benign0.01Affected3.7752-33.630.03
c.2218C>TR740WUncertain 26-33441683-C-T63.72e-6-8.561Likely Pathogenic0.168Likely BenignLikely Benign0.180Likely Benign-3.09Deleterious1.000Probably Damaging0.938Probably Damaging2.52Benign0.01Affected4.3222-33.630.03
c.3595G>AE1199KCoiled-coilUncertain 16-33446587-G-A16.20e-7-10.853Likely Pathogenic0.954Likely PathogenicAmbiguous0.171Likely Benign-2.26Neutral1.000Probably Damaging0.995Probably Damaging2.52Benign0.00Affected3.77501-0.4-0.94
c.3175G>AG1059RUncertain 16-33443727-G-A684.23e-5-8.452Likely Pathogenic0.376AmbiguousLikely Benign0.333Likely Benign-0.55Neutral0.001Benign0.001Benign2.53Benign0.00Affected4.322-3-2-4.199.14
c.1802C>AA601E
(3D Viewer)
Likely PathogenicGAPConflicting 2-16.752Likely Pathogenic0.992Likely PathogenicLikely Pathogenic0.588Likely Pathogenic6.68Destabilizing0.85.76Destabilizing6.22Destabilizing1.24Destabilizing-4.98Deleterious1.000Probably Damaging0.999Probably Damaging2.54Benign0.00Affected3.37350-1-5.358.04240.0-82.30.00.00.70.1XXXPotentially PathogenicThe methyl side chain of Ala601, located on an α helix (res. Glu582-Met603), packs hydrophobically against other hydrophobic residues in the inter-helix space (e.g., Phe597, Leu598, Leu506, Phe608).In the variant simulations, the carboxylate group of Glu601 faces the inter-helix space and is forced to shift slightly away from the hydrophobic niche. Additionally, in two of the simulations, Glu601 forms a salt bridge with Arg499, causing the otherwise stable salt bridge between Arg499 and Glu496 at the outer surface of an α helix (res. Leu489-Glu519) to break due to the residue swap.These effects suggest that the protein folding process could be seriously affected. Moreover, due to its location at the GAP-Ras interface, it could also impact the complex formation with the GTPase.
c.2506A>GS836GLikely BenignUncertain 16-33443058-A-G42.48e-6-4.749Likely Benign0.112Likely BenignLikely Benign0.066Likely Benign-1.65Neutral0.006Benign0.019Benign2.54Benign0.39Tolerated3.775100.4-30.03
c.2521G>AV841MUncertain 16-33443073-G-A31.86e-6-7.000In-Between0.651Likely PathogenicLikely Benign0.119Likely Benign-0.74Neutral0.999Probably Damaging0.998Probably Damaging2.54Benign0.02Affected3.77512-2.332.06
c.3142G>CG1048RLikely BenignUncertain 1-4.305Likely Benign0.435AmbiguousLikely Benign0.503Likely Pathogenic-0.54Neutral0.919Possibly Damaging0.728Possibly Damaging2.54Benign0.10Tolerated3.775-2-3-4.199.14
c.3824G>TR1275LLikely Benign 16-33447872-G-T16.45e-7-6.052Likely Benign0.446AmbiguousLikely Benign0.117Likely Benign-4.04Deleterious0.800Possibly Damaging0.277Benign2.55Benign0.01Affected3.775-3-28.3-43.03
c.2502G>CM834ILikely BenignUncertain 1-3.377Likely Benign0.291Likely BenignLikely Benign0.055Likely Benign-1.21Neutral0.026Benign0.009Benign2.56Benign0.00Affected4.324122.6-18.03
c.2650C>TR884WLikely BenignUncertain 16-33443202-C-T53.10e-6-3.785Likely Benign0.332Likely BenignLikely Benign0.151Likely Benign0.26Neutral0.995Probably Damaging0.812Possibly Damaging2.56Benign0.05Affected4.324-323.630.03
c.3176G>CG1059ALikely BenignUncertain 16-33443728-G-C42.49e-6-6.754Likely Benign0.081Likely BenignLikely Benign0.329Likely Benign-0.17Neutral0.001Benign0.002Benign2.56Benign0.00Affected4.322102.214.03
c.3260C>TS1087FUncertain 1-3.843Likely Benign0.497AmbiguousLikely Benign0.105Likely Benign-2.75Deleterious0.990Probably Damaging0.796Possibly Damaging2.56Benign0.03Affected3.775-2-33.660.10
c.3662G>AR1221QLikely BenignCoiled-coilConflicting 26-33446654-G-A42.48e-6-5.491Likely Benign0.115Likely BenignLikely Benign0.078Likely Benign-1.46Neutral0.836Possibly Damaging0.153Benign2.56Benign0.12Tolerated3.775111.0-28.06
c.2215G>CE739QLikely BenignUncertain 1-2.846Likely Benign0.161Likely BenignLikely Benign0.071Likely Benign-1.06Neutral0.801Possibly Damaging0.339Benign2.57Benign0.00Affected4.322220.0-0.98
c.2522T>CV841AUncertain 16-33443074-T-C31.86e-6-8.152Likely Pathogenic0.901Likely PathogenicAmbiguous0.183Likely Benign-2.13Neutral0.992Probably Damaging0.989Probably Damaging2.57Benign0.02Affected3.77500-2.4-28.05
c.2627C>TS876LUncertain 2-5.856Likely Benign0.489AmbiguousLikely Benign0.249Likely Benign-3.56Deleterious0.998Probably Damaging0.992Probably Damaging2.57Benign0.05Affected3.775-2-34.626.08
c.2713C>TR905CConflicting 26-33443265-C-T159.31e-6-5.578Likely Benign0.723Likely PathogenicLikely Benign0.194Likely Benign-3.14Deleterious1.000Probably Damaging0.980Probably Damaging2.57Benign0.01Affected3.775-4-37.0-53.05
c.2765G>AR922QLikely BenignBenign 16-33443317-G-A74.34e-6-3.295Likely Benign0.189Likely BenignLikely Benign0.085Likely Benign-0.27Neutral0.992Probably Damaging0.736Possibly Damaging2.57Benign0.20Tolerated3.775111.0-28.06
c.2724G>CQ908HLikely BenignConflicting 46-33443276-G-C16.20e-7-4.658Likely Benign0.311Likely BenignLikely Benign0.112Likely Benign-0.74Neutral0.996Probably Damaging0.995Probably Damaging2.58Benign0.05Affected3.775300.39.01
c.3338G>AG1113DLikely BenignUncertain 16-33443890-G-A-4.638Likely Benign0.354AmbiguousLikely Benign0.061Likely Benign-0.72Neutral0.029Benign0.017Benign2.58Benign0.34Tolerated4.322-11-3.158.04
c.2195G>CR732TUncertain 1-8.545Likely Pathogenic0.434AmbiguousLikely Benign0.075Likely Benign-1.96Neutral0.999Probably Damaging0.892Possibly Damaging2.59Benign0.12Tolerated3.597-1-13.8-55.08
c.2217G>CE739DLikely BenignUncertain 1-3.369Likely Benign0.062Likely BenignLikely Benign0.097Likely Benign-0.49Neutral0.002Benign0.005Benign2.59Benign0.00Affected320.0-14.03
c.2245C>TR749WLikely Benign 16-33441710-C-T31.86e-6-7.647In-Between0.338Likely BenignLikely Benign0.173Likely Benign-2.62Deleterious1.000Probably Damaging0.998Probably Damaging2.59Benign0.00Affected4.3222-33.630.03
c.2339C>GS780CLikely BenignUncertain 46-33442891-C-G169.94e-6-7.603In-Between0.278Likely BenignLikely Benign0.078Likely Benign-1.41Neutral0.065Benign0.043Benign2.59Benign0.10Tolerated3.646-103.316.06
c.2443C>TR815CLikely PathogenicSH3-binding motifUncertain 16-33442995-C-T53.10e-6-9.373Likely Pathogenic0.828Likely PathogenicAmbiguous0.174Likely Benign-3.89Deleterious1.000Probably Damaging0.998Probably Damaging2.59Benign0.00Affected4.324-4-37.0-53.05
c.2714G>AR905HLikely BenignUncertain 16-33443266-G-A84.96e-6-4.182Likely Benign0.457AmbiguousLikely Benign0.192Likely Benign-1.11Neutral1.000Probably Damaging0.991Probably Damaging2.59Benign0.09Tolerated3.775201.3-19.05
c.3824G>AR1275QLikely BenignUncertain 16-33447872-G-A21.29e-6-4.928Likely Benign0.121Likely BenignLikely Benign0.103Likely Benign-1.72Neutral0.898Possibly Damaging0.147Benign2.59Benign0.03Affected3.775111.0-28.06
c.1513T>GY505D
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-14.078Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.718Likely Pathogenic4.98Destabilizing0.14.72Destabilizing4.85Destabilizing2.49Destabilizing-9.95Deleterious1.000Probably Damaging1.000Probably Damaging2.60Benign0.00Affected3.3735-3-4-2.2-48.09
c.2219G>AR740QLikely BenignUncertain 16-33441684-G-A42.48e-6-5.195Likely Benign0.078Likely BenignLikely Benign0.102Likely Benign-0.67Neutral0.999Probably Damaging0.881Possibly Damaging2.60Benign0.08Tolerated4.322111.0-28.06
c.2719A>TS907CLikely BenignLikely Benign 1-6.685Likely Benign0.298Likely BenignLikely Benign0.113Likely Benign-2.34Neutral0.999Probably Damaging0.988Probably Damaging2.60Benign0.02Affected3.7750-13.316.06
c.3494C>TS1165LLikely BenignConflicting 2-2.984Likely Benign0.793Likely PathogenicAmbiguous0.166Likely Benign-2.01Neutral0.998Probably Damaging0.992Probably Damaging2.60Benign0.33Tolerated3.883-3-24.626.0810.1016/j.ajhg.2020.11.011
c.2444G>AR815HSH3-binding motifLikely Benign 26-33442996-G-A241.49e-5-7.474In-Between0.553AmbiguousLikely Benign0.157Likely Benign-1.81Neutral1.000Probably Damaging0.998Probably Damaging2.61Benign0.02Affected4.324201.3-19.0510.1016/j.ajhg.2020.11.011
c.2704G>AA902TLikely BenignLikely Benign 16-33443256-G-A362.23e-5-4.966Likely Benign0.116Likely BenignLikely Benign0.075Likely Benign-1.11Neutral0.951Possibly Damaging0.617Possibly Damaging2.61Benign0.01Affected3.77510-2.530.03
c.2753C>TA918VLikely BenignUncertain 36-33443305-C-T21.24e-6-3.684Likely Benign0.112Likely BenignLikely Benign0.119Likely Benign-1.61Neutral0.980Probably Damaging0.782Possibly Damaging2.61Benign0.03Affected4.324002.428.05
c.2443C>GR815GSH3-binding motifUncertain 1-7.983In-Between0.854Likely PathogenicAmbiguous0.146Likely Benign-3.22Deleterious0.999Probably Damaging0.997Probably Damaging2.62Benign0.02Affected4.324-3-24.1-99.14
c.2651G>AR884QLikely BenignUncertain 26-33443203-G-A53.10e-6-3.785Likely Benign0.128Likely BenignLikely Benign0.055Likely Benign-0.42Neutral0.012Benign0.004Benign2.62Benign0.36Tolerated4.324111.0-28.06
c.3442A>TM1148LLikely BenignUncertain 1-1.777Likely Benign0.093Likely BenignLikely Benign0.068Likely Benign-1.13Neutral0.016Benign0.016Benign2.62Benign0.00Affected4.322421.9-18.03
c.2444G>TR815LLikely PathogenicSH3-binding motifUncertain 1-8.546Likely Pathogenic0.865Likely PathogenicAmbiguous0.175Likely Benign-3.06Deleterious0.999Probably Damaging0.997Probably Damaging2.63Benign0.03Affected4.324-2-38.3-43.03
c.3179G>TG1060VLikely BenignBenign 16-33443731-G-T16.22e-7-6.966Likely Benign0.103Likely BenignLikely Benign0.369Likely Benign-0.73Neutral0.986Probably Damaging0.728Possibly Damaging2.63Benign0.33Tolerated4.322-1-34.642.08
c.3262A>GS1088GLikely BenignUncertain 1-5.034Likely Benign0.285Likely BenignLikely Benign0.163Likely Benign-1.83Neutral0.979Probably Damaging0.973Probably Damaging2.63Benign0.03Affected3.775010.4-30.03
c.1513T>CY505H
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-11.383Likely Pathogenic0.982Likely PathogenicLikely Pathogenic0.646Likely Pathogenic2.91Destabilizing0.12.88Destabilizing2.90Destabilizing1.60Destabilizing-4.97Deleterious1.000Probably Damaging1.000Probably Damaging2.64Benign0.00Affected3.373520-1.9-26.03
c.2246G>AR749QLikely BenignLikely Benign 16-33441711-G-A42.48e-6-3.069Likely Benign0.212Likely BenignLikely Benign0.152Likely Benign-1.00Neutral0.999Probably Damaging0.994Probably Damaging2.64Benign0.03Affected4.322111.0-28.06
c.2493G>CE831DLikely BenignUncertain 16-33443045-G-C16.19e-7-3.055Likely Benign0.063Likely BenignLikely Benign0.073Likely Benign1.23Neutral0.002Benign0.002Benign2.64Benign0.77Tolerated3.775320.0-14.03
c.2608C>GL870VLikely BenignUncertain 1-4.123Likely Benign0.300Likely BenignLikely Benign0.111Likely Benign-1.19Neutral0.997Probably Damaging0.992Probably Damaging2.64Benign0.12Tolerated3.883210.4-14.03
c.2684G>AS895NLikely BenignUncertain 1-6.399Likely Benign0.604Likely PathogenicLikely Benign0.118Likely Benign-0.85Neutral0.991Probably Damaging0.988Probably Damaging2.64Benign0.30Tolerated4.32411-2.727.03
c.2702C>TA901VLikely BenignUncertain 26-33443254-C-T21.24e-6-5.043Likely Benign0.219Likely BenignLikely Benign0.029Likely Benign-1.83Neutral0.106Benign0.009Benign2.64Benign0.17Tolerated3.775002.428.05
c.2741A>TD914VLikely BenignUncertain 1-4.260Likely Benign0.723Likely PathogenicLikely Benign0.187Likely Benign-2.24Neutral0.999Probably Damaging0.986Probably Damaging2.64Benign0.01Affected3.775-3-27.7-15.96
c.2752G>AA918TLikely BenignUncertain 16-33443304-G-A16.20e-7-4.139Likely Benign0.083Likely BenignLikely Benign0.065Likely Benign-1.09Neutral0.980Probably Damaging0.721Possibly Damaging2.64Benign0.03Affected4.32401-2.530.03
c.3038C>GS1013CLikely BenignUncertain 16-33443590-C-G42.48e-6-6.745Likely Benign0.110Likely BenignLikely Benign0.058Likely Benign-2.06Neutral0.898Possibly Damaging0.579Possibly Damaging2.64Benign0.05Affected3.7750-13.316.06
c.3048C>AD1016ELikely BenignLikely Benign 16-33443600-C-A21.24e-6-3.422Likely Benign0.216Likely BenignLikely Benign0.017Likely Benign-0.37Neutral0.008Benign0.028Benign2.64Benign0.65Tolerated3.775230.014.03
c.3134C>GA1045GLikely BenignBenign/Likely benign 76-33443686-C-G14078.72e-4-3.246Likely Benign0.075Likely BenignLikely Benign0.024Likely Benign-1.21Neutral0.224Benign0.066Benign2.64Benign0.33Tolerated3.77510-2.2-14.0310.1016/j.ajhg.2020.11.011
c.3290C>TP1097LLikely BenignBenign 1-4.410Likely Benign0.145Likely BenignLikely Benign0.131Likely Benign-2.07Neutral0.611Possibly Damaging0.198Benign2.64Benign0.05Affected3.775-3-35.416.04
c.3424T>CS1142PLikely BenignLikely Benign 16-33444459-T-C16.20e-7-2.713Likely Benign0.222Likely BenignLikely Benign0.107Likely Benign-2.19Neutral0.918Possibly Damaging0.761Possibly Damaging2.64Benign0.00Affected4.324-11-0.810.04
c.2291A>GN764SLikely BenignBenign 1-3.149Likely Benign0.159Likely BenignLikely Benign0.058Likely Benign-0.84Neutral0.992Probably Damaging0.846Possibly Damaging2.65Benign0.61Tolerated3.646112.7-27.03
c.2954G>AS985NLikely BenignUncertain 1-6.979Likely Benign0.845Likely PathogenicAmbiguous0.088Likely Benign-1.68Neutral0.991Probably Damaging0.988Probably Damaging2.65Benign0.00Affected4.32111-2.727.03
c.3002T>CL1001PLikely BenignUncertain 1-3.071Likely Benign0.209Likely BenignLikely Benign0.113Likely Benign-1.02Neutral0.966Probably Damaging0.690Possibly Damaging2.65Benign0.00Affected4.324-3-3-5.4-16.04
c.3020G>AS1007NLikely BenignBenign 1-5.113Likely Benign0.803Likely PathogenicAmbiguous0.075Likely Benign-1.54Neutral0.997Probably Damaging0.992Probably Damaging2.65Benign0.01Affected3.77511-2.727.03
c.3023A>GD1008GUncertain 16-33443575-A-G16.20e-7-3.213Likely Benign0.742Likely PathogenicLikely Benign0.203Likely Benign-2.84Deleterious0.999Probably Damaging0.997Probably Damaging2.65Benign0.01Affected3.775-113.1-58.04
c.3049T>CF1017LLikely BenignBenign 1-2.048Likely Benign0.934Likely PathogenicAmbiguous0.157Likely Benign-2.38Neutral0.798Possibly Damaging0.373Benign2.65Benign0.72Tolerated3.775021.0-34.02
c.3326T>CL1109PLikely BenignConflicting 2-5.313Likely Benign0.120Likely BenignLikely Benign0.151Likely Benign-0.52Neutral0.002Benign0.003Benign2.65Benign0.07Tolerated4.322-3-3-5.4-16.04
c.3557C>TS1186LCoiled-coilUncertain 16-33444592-C-T-4.829Likely Benign0.923Likely PathogenicAmbiguous0.177Likely Benign-2.58Deleterious0.998Probably Damaging0.992Probably Damaging2.65Benign0.04Affected3.824-3-24.626.08
c.2224C>TR742WLikely BenignUncertain 16-33441689-C-T63.72e-6-7.725In-Between0.133Likely BenignLikely Benign0.079Likely Benign-1.71Neutral0.992Probably Damaging0.684Possibly Damaging2.66Benign0.01Affected4.322-323.630.03
c.2690C>TS897LLikely BenignUncertain 1-4.034Likely Benign0.299Likely BenignLikely Benign0.028Likely Benign-1.71Neutral0.901Possibly Damaging0.636Possibly Damaging2.66Benign0.01Affected-3-24.626.08
c.2239G>CV747LLikely BenignUncertain 16-33441704-G-C21.24e-6-2.790Likely Benign0.096Likely BenignLikely Benign0.047Likely Benign-0.52Neutral0.065Benign0.033Benign2.67Benign0.00Affected4.32221-0.414.03
c.2443C>AR815SSH3-binding motifBenign 1-7.324In-Between0.950Likely PathogenicAmbiguous0.138Likely Benign-1.86Neutral0.999Probably Damaging0.997Probably Damaging2.67Benign0.02Affected0-13.7-69.11
c.2503C>AL835MLikely BenignBenign 1-4.153Likely Benign0.121Likely BenignLikely Benign0.068Likely Benign-0.45Neutral0.999Probably Damaging0.977Probably Damaging2.67Benign0.12Tolerated3.77524-1.918.03
c.2619C>GS873RUncertain 16-33443171-C-G16.20e-7-5.856Likely Benign0.976Likely PathogenicLikely Pathogenic0.192Likely Benign-2.74Deleterious0.997Probably Damaging0.995Probably Damaging2.67Benign0.06Tolerated3.7750-1-3.769.11
c.3092T>CM1031TLikely BenignUncertain 16-33443644-T-C21.24e-6-1.863Likely Benign0.540AmbiguousLikely Benign0.085Likely Benign-0.24Neutral0.002Benign0.005Benign2.67Benign1.00Tolerated3.775-1-1-2.6-30.09
c.2435C>AP812HSH3-binding motifUncertain 26-33442987-C-A31.86e-6-7.470In-Between0.698Likely PathogenicLikely Benign0.272Likely Benign-2.81Deleterious1.000Probably Damaging0.995Probably Damaging2.68Benign0.00Affected4.3240-2-1.640.02
c.2459A>GY820CLikely PathogenicUncertain 1-8.797Likely Pathogenic0.744Likely PathogenicLikely Benign0.113Likely Benign-3.16Deleterious1.000Probably Damaging0.983Probably Damaging2.68Benign0.06Tolerated3.7750-23.8-60.04
c.2681G>AG894ELikely BenignUncertain 16-33443233-G-A63.72e-6-5.377Likely Benign0.859Likely PathogenicAmbiguous0.180Likely Benign-2.07Neutral1.000Probably Damaging1.000Probably Damaging2.68Benign0.01Affected4.3240-2-3.172.06
c.2750C>GP917RLikely BenignUncertain 16-33443302-C-G53.10e-6-4.475Likely Benign0.363AmbiguousLikely Benign0.142Likely Benign-1.70Neutral0.642Possibly Damaging0.316Benign2.68Benign0.00Affected3.775-20-2.959.07
c.2809G>CD937HLikely BenignUncertain 1-0.733Likely Benign0.677Likely PathogenicLikely Benign0.150Likely Benign-1.74Neutral1.000Probably Damaging0.975Probably Damaging2.68Benign0.13Tolerated3.775-110.322.05
c.3572G>AR1191QLikely BenignCoiled-coilUncertain 26-33444607-G-A95.58e-6-1.069Likely Benign0.943Likely PathogenicAmbiguous0.343Likely Benign-1.41Neutral0.998Probably Damaging0.992Probably Damaging2.68Benign0.08Tolerated3.824111.0-28.06
c.2195G>AR732KLikely BenignConflicting 26-33441660-G-A42.48e-6-5.278Likely Benign0.240Likely BenignLikely Benign0.045Likely Benign-0.82Neutral0.973Probably Damaging0.943Probably Damaging2.69Benign0.21Tolerated3.597320.6-28.01
c.2214T>GS738RLikely BenignBenign 16-33441679-T-G16.20e-7-4.241Likely Benign0.570Likely PathogenicLikely Benign0.068Likely Benign-1.55Neutral0.473Possibly Damaging0.193Benign2.69Benign0.01Affected4.3220-1-3.769.11
c.2282G>CR761PLikely BenignUncertain 36-33441747-G-C16.20e-7-5.091Likely Benign0.640Likely PathogenicLikely Benign0.201Likely Benign-1.89Neutral0.999Probably Damaging0.968Probably Damaging2.69Benign0.38Tolerated3.9950-22.9-59.07
c.2514C>AN838KLikely PathogenicUncertain 2-8.470Likely Pathogenic0.862Likely PathogenicAmbiguous0.097Likely Benign-2.78Deleterious0.997Probably Damaging0.995Probably Damaging2.69Benign0.16Tolerated3.77510-0.414.07
c.2596G>AV866ILikely BenignConflicting 36-33443148-G-A53.10e-6-4.652Likely Benign0.118Likely BenignLikely Benign0.059Likely Benign-0.39Neutral0.957Probably Damaging0.541Possibly Damaging2.69Benign0.27Tolerated3.824430.314.03
c.2635_2636delinsAAA879KLikely BenignLikely Benign 1-5.877Likely Benign0.757Likely PathogenicLikely Benign-0.71Neutral0.969Probably Damaging0.593Possibly Damaging2.69Benign0.21Tolerated3.775-1-1-5.757.10
c.2962C>TL988FLikely BenignUncertain 16-33443514-C-T16.20e-7-4.368Likely Benign0.356AmbiguousLikely Benign0.135Likely Benign-1.70Neutral0.977Probably Damaging0.900Possibly Damaging2.69Benign0.00Affected4.32220-1.034.02
c.3178G>AG1060SLikely BenignUncertain 16-33443730-G-A-4.759Likely Benign0.082Likely BenignLikely Benign0.376Likely Benign-0.08Neutral0.271Benign0.054Benign2.69Benign0.49Tolerated4.32210-0.430.03
c.3574C>GL1192VLikely BenignCoiled-coilUncertain 1-4.132Likely Benign0.471AmbiguousLikely Benign0.041Likely Benign-0.89Neutral0.779Possibly Damaging0.527Possibly Damaging2.69Benign0.16Tolerated210.4-14.03
c.3705G>AM1235ILikely BenignCoiled-coilUncertain 1-4.312Likely Benign0.310Likely BenignLikely Benign0.027Likely Benign-1.44Neutral0.139Benign0.056Benign2.69Benign0.04Affected3.775122.6-18.03
c.1898T>CL633P
(3D Viewer)
Likely PathogenicGAPPathogenic/Likely path. 2-15.669Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.693Likely Pathogenic6.60Destabilizing0.210.15Destabilizing8.38Destabilizing2.42Destabilizing-6.97Deleterious1.000Probably Damaging1.000Probably Damaging2.70Benign0.00Affected3.3734-3-3-5.4-16.04193.265.10.00.00.10.0XPotentially PathogenicThe iso-butyl side chain of Leu633, located in the middle of an α helix (res. Glu617-Asn635), packs hydrophobically with nearby residues (e.g., Leu653, Val629, Leu551) in the WT simulations.In the variant simulations, the pyrrolidine side chain of Pro633 is not as optimal for hydrophobic packing as Leu633 in the WT. Additionally, proline lacks a free backbone amide group, so Pro633 cannot form a hydrogen bond with the backbone carbonyl group of Val629, which disrupts the continuity of the secondary structure element.
c.2768T>AI923NLikely BenignUncertain 1-0.733Likely Benign0.712Likely PathogenicLikely Benign0.108Likely Benign-1.16Neutral0.991Probably Damaging0.793Possibly Damaging2.70Benign0.13Tolerated3.775-2-3-8.00.94
c.3253C>TR1085WUncertain 16-33443805-C-T21.26e-6-6.339Likely Benign0.821Likely PathogenicAmbiguous0.202Likely Benign-3.15Deleterious1.000Probably Damaging0.996Probably Damaging2.70Benign0.00Affected3.775-323.630.03
c.3846G>CE1282DLikely BenignUncertain 16-33447894-G-C16.44e-7-3.879Likely Benign0.074Likely BenignLikely Benign0.104Likely Benign-1.26Neutral0.112Benign0.036Benign2.70Benign0.39Tolerated3.775320.0-14.03
c.2596G>TV866LLikely BenignUncertain 16-33443148-G-T16.20e-7-3.352Likely Benign0.148Likely BenignLikely Benign0.046Likely Benign-0.97Neutral0.217Benign0.229Benign2.71Benign0.21Tolerated3.82421-0.414.03
c.3835G>AA1279TLikely BenignUncertain 26-33447883-G-A21.29e-6-4.871Likely Benign0.071Likely BenignLikely Benign0.178Likely Benign-0.30Neutral0.001Benign0.000Benign2.71Benign0.09Tolerated3.77510-2.530.03
c.1784T>CL595P
(3D Viewer)
Likely PathogenicGAPUncertain 1-11.856Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.747Likely Pathogenic2.09Destabilizing0.85.88Destabilizing3.99Destabilizing1.78Destabilizing-6.97Deleterious1.000Probably Damaging1.000Probably Damaging2.72Benign0.00Affected3.3735-3-3-5.4-16.04
c.2405G>AG802DLikely BenignSH3-binding motifUncertain 16-33442957-G-A16.20e-7-5.083Likely Benign0.476AmbiguousLikely Benign0.153Likely Benign-0.38Neutral0.126Benign0.138Benign2.72Benign0.09Tolerated3.7751-1-3.158.04
c.2623G>AA875TLikely BenignUncertain 16-33443175-G-A16.20e-7-3.793Likely Benign0.179Likely BenignLikely Benign0.110Likely Benign-1.56Neutral0.972Probably Damaging0.864Possibly Damaging2.72Benign0.26Tolerated3.77501-2.530.03
c.3041G>TG1014VLikely BenignUncertain 1-4.612Likely Benign0.181Likely BenignLikely Benign0.053Likely Benign-2.47Neutral0.818Possibly Damaging0.377Benign2.72Benign0.06Tolerated3.775-1-34.642.08
c.3103C>AP1035TLikely BenignUncertain 1-4.447Likely Benign0.426AmbiguousLikely Benign0.087Likely Benign-0.96Neutral0.901Possibly Damaging0.537Possibly Damaging2.72Benign0.23Tolerated3.7750-10.93.99
c.3197C>TP1066LLikely BenignLikely Benign 16-33443749-C-T148.71e-6-5.478Likely Benign0.092Likely BenignLikely Benign0.173Likely Benign-3.68Deleterious0.996Probably Damaging0.903Possibly Damaging2.72Benign0.00Affected4.322-3-35.416.04
c.3932T>CL1311PLikely BenignLikely Benign 16-33451806-T-C16.21e-7-1.831Likely Benign0.079Likely BenignLikely Benign0.123Likely Benign-0.52Neutral0.579Possibly Damaging0.335Benign2.72Benign0.18Tolerated3.775-3-3-5.4-16.04
c.2225G>AR742QLikely BenignUncertain 26-33441690-G-A241.49e-5-4.090Likely Benign0.068Likely BenignLikely Benign0.054Likely Benign-0.19Neutral0.032Benign0.007Benign2.73Benign0.07Tolerated4.322111.0-28.06
c.2243T>GL748RLikely BenignConflicting 26-33441708-T-G31.86e-6-3.331Likely Benign0.245Likely BenignLikely Benign0.055Likely Benign-0.67Neutral0.912Possibly Damaging0.448Possibly Damaging2.73Benign0.02Affected4.322-3-2-8.343.03
c.2270G>CG757ALikely BenignUncertain 1-2.626Likely Benign0.091Likely BenignLikely Benign0.066Likely Benign-0.45Neutral0.267Benign0.127Benign2.73Benign0.35Tolerated102.214.03
c.2632A>GT878ALikely BenignUncertain 1-2.154Likely Benign0.081Likely BenignLikely Benign0.088Likely Benign-0.67Neutral0.003Benign0.006Benign2.73Benign0.18Tolerated3.775102.5-30.03
c.2743G>AG915SLikely BenignBenign 16-33443295-G-A95.58e-6-3.557Likely Benign0.083Likely BenignLikely Benign0.050Likely Benign-0.88Neutral0.801Possibly Damaging0.201Benign2.73Benign0.31Tolerated3.77510-0.430.03
c.2818G>CG940RLikely BenignBenign 16-33443370-G-C53.10e-6-6.169Likely Benign0.480AmbiguousLikely Benign0.060Likely Benign0.02Neutral0.922Possibly Damaging0.543Possibly Damaging2.73Benign0.15Tolerated3.775-3-2-4.199.14
c.3254G>AR1085QLikely BenignUncertain 16-33443806-G-A53.16e-6-3.843Likely Benign0.589Likely PathogenicLikely Benign0.224Likely Benign-1.43Neutral0.998Probably Damaging0.988Probably Damaging2.73Benign0.02Affected3.775111.0-28.06
c.3484C>TP1162SLikely BenignUncertain 1-2.118Likely Benign0.913Likely PathogenicAmbiguous0.215Likely Benign-1.93Neutral1.000Probably Damaging0.999Probably Damaging2.73Benign0.55Tolerated3.8831-10.8-10.04
c.1802C>TA601V
(3D Viewer)
Likely PathogenicGAPUncertain 1-10.447Likely Pathogenic0.853Likely PathogenicAmbiguous0.535Likely Pathogenic1.64Ambiguous0.10.35Likely Benign1.00Ambiguous0.81Ambiguous-3.98Deleterious1.000Probably Damaging0.989Probably Damaging2.74Benign0.03Affected3.3735002.428.05228.5-45.50.00.00.40.5XPotentially BenignThe methyl side chain of Ala601, located on an α helix (res. Glu582-Met603), packs hydrophobically against other hydrophobic residues in the inter-helix space (e.g., Phe597, Leu598, Leu506, Phe608).In the variant simulations, Val601, which has similar size and physicochemical properties to alanine, resides in the inter-helix hydrophobic space in a similar manner to Ala601 in the WT, causing no apparent negative effect on the protein structure. However, the effect of the residue swap on the SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.2458T>AY820NUncertain 1-9.032Likely Pathogenic0.842Likely PathogenicAmbiguous0.143Likely Benign-1.53Neutral0.999Probably Damaging0.977Probably Damaging2.74Benign0.20Tolerated-2-2-2.2-49.07
c.2812G>AG938RLikely BenignUncertain 1-5.271Likely Benign0.732Likely PathogenicLikely Benign0.141Likely Benign-1.11Neutral0.999Probably Damaging0.985Probably Damaging2.74Benign0.36Tolerated3.775-3-2-4.199.14
c.3196C>TP1066SLikely BenignLikely Pathogenic 1-4.746Likely Benign0.070Likely BenignLikely Benign0.145Likely Benign-2.47Neutral0.972Probably Damaging0.850Possibly Damaging2.74Benign0.00Affected4.3221-10.8-10.04
c.3638A>CN1213TLikely BenignCoiled-coilConflicting 26-33446630-A-C462.85e-5-5.428Likely Benign0.266Likely BenignLikely Benign0.097Likely Benign-1.08Neutral0.959Probably Damaging0.721Possibly Damaging2.74Benign1.00Tolerated3.775002.8-13.00
c.1784T>AL595Q
(3D Viewer)
Likely PathogenicGAPUncertain 1-15.101Likely Pathogenic0.984Likely PathogenicLikely Pathogenic0.733Likely Pathogenic0.79Ambiguous0.11.40Ambiguous1.10Ambiguous1.99Destabilizing-5.97Deleterious1.000Probably Damaging1.000Probably Damaging2.75Benign0.00Affected3.3735-2-2-7.314.97
c.2282G>AR761QLikely BenignUncertain 16-33441747-G-A116.81e-6-4.187Likely Benign0.202Likely BenignLikely Benign0.191Likely Benign-0.63Neutral0.996Probably Damaging0.878Possibly Damaging2.75Benign0.40Tolerated3.995111.0-28.06
c.2695A>GI899VLikely BenignBenign 16-33443247-A-G63.72e-6-2.569Likely Benign0.074Likely BenignLikely Benign0.040Likely Benign0.09Neutral0.220Benign0.078Benign2.75Benign0.92Tolerated4.32443-0.3-14.03
c.3022G>AD1008NLikely BenignLikely Benign 16-33443574-G-A31.86e-6-4.045Likely Benign0.714Likely PathogenicLikely Benign0.128Likely Benign-2.15Neutral0.999Probably Damaging0.997Probably Damaging2.75Benign0.01Affected3.775210.0-0.98
c.3116T>CI1039TLikely BenignUncertain 16-33443668-T-C127.43e-6-2.465Likely Benign0.645Likely PathogenicLikely Benign0.193Likely Benign0.45Neutral0.004Benign0.008Benign2.75Benign0.10Tolerated3.775-10-5.2-12.05
c.3223C>AQ1075KLikely BenignUncertain 1-5.135Likely Benign0.728Likely PathogenicLikely Benign0.134Likely Benign-0.67Neutral0.963Probably Damaging0.959Probably Damaging2.75Benign1.00Tolerated3.77511-0.40.04
c.2401G>AG801SLikely BenignSH3-binding motifUncertain 1-3.665Likely Benign0.087Likely BenignLikely Benign0.039Likely Benign-0.41Neutral0.009Benign0.019Benign2.76Benign0.48Tolerated4.32201-0.430.03
c.2822C>TP941LLikely BenignUncertain 2-5.692Likely Benign0.066Likely BenignLikely Benign0.054Likely Benign-0.44Neutral0.144Benign0.039Benign2.76Benign0.01Affected-3-35.416.04
c.2998A>GI1000VLikely BenignUncertain 2-4.102Likely Benign0.098Likely BenignLikely Benign0.086Likely Benign-0.20Neutral0.437Benign0.170Benign2.76Benign0.81Tolerated4.32434-0.3-14.03
c.3293G>AS1098NLikely BenignConflicting 26-33443845-G-A63.89e-6-5.120Likely Benign0.156Likely BenignLikely Benign0.063Likely Benign-0.58Neutral0.369Benign0.120Benign2.76Benign0.36Tolerated3.77511-2.727.03
c.3344T>CI1115TLikely BenignBenign 96-33443896-T-C205361.36e-2-2.670Likely Benign0.068Likely BenignLikely Benign0.100Likely Benign-0.04Neutral0.000Benign0.001Benign2.76Benign0.23Tolerated4.3220-1-5.2-12.05
c.3848C>TP1283LLikely BenignBenign 16-33447896-C-T322.06e-5-3.740Likely Benign0.093Likely BenignLikely Benign0.047Likely Benign-1.04Neutral0.005Benign0.003Benign2.76Benign0.06Tolerated3.775-3-35.416.04
c.3860C>TP1287LLikely BenignConflicting 26-33447908-C-T-2.800Likely Benign0.117Likely BenignLikely Benign0.061Likely Benign-1.66Neutral0.021Benign0.017Benign2.76Benign0.02Affected3.775-3-35.416.04
c.1778T>CL593P
(3D Viewer)
Likely PathogenicGAPUncertain 1-13.961Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.777Likely Pathogenic5.75Destabilizing0.910.77Destabilizing8.26Destabilizing2.43Destabilizing-6.77Deleterious1.000Probably Damaging1.000Probably Damaging2.77Benign0.00Affected-3-3-5.4-16.04
c.2200C>TP734SLikely BenignUncertain 26-33441665-C-T21.24e-6-4.291Likely Benign0.077Likely BenignLikely Benign0.030Likely Benign-2.44Neutral0.344Benign0.048Benign2.77Benign0.11Tolerated3.6461-10.8-10.0410.1016/j.ajhg.2020.11.011
c.1778T>AL593H
(3D Viewer)
Likely PathogenicGAPUncertain 1-16.504Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.812Likely Pathogenic2.52Destabilizing0.22.32Destabilizing2.42Destabilizing2.75Destabilizing-6.77Deleterious1.000Probably Damaging1.000Probably Damaging2.77Benign0.00Affected3.3735-2-3-7.023.98222.020.70.00.00.20.0XXPotentially PathogenicThe iso-propyl side chain of Leu593, located in an α helix (res. Glu582-Met603), packs favourably with multiple hydrophobic residues in the inter-helix space (e.g., Leu598, Ile589, Phe594, Phe561).In the variant simulations, His593 retains a similar packing arrangement via its aromatic imidazole ring. However, the polar nitrogen atoms introduce hydrogen bond donors and acceptors into the previously hydrophobic space. The epsilon protonated nitrogen of His593 forms a stable hydrogen bond with the phenol group of the Tyr505 side chain in an α helix (res. Gln503-Tyr518).While the residue swap could affect the tertiary assembly and the underlying protein folding process, it is difficult to determine if the mutation would be tolerated based solely on the variant simulations.
c.2818G>AG940SLikely BenignUncertain 16-33443370-G-A16.20e-7-5.451Likely Benign0.084Likely BenignLikely Benign0.135Likely Benign0.45Neutral0.409Benign0.253Benign2.77Benign0.44Tolerated3.77510-0.430.03
c.3287A>CE1096ALikely BenignUncertain 1-4.504Likely Benign0.510AmbiguousLikely Benign0.164Likely Benign-1.37Neutral0.626Possibly Damaging0.184Benign2.77Benign0.16Tolerated3.775-105.3-58.04
c.3310C>TP1104SLikely BenignBenign 16-33443862-C-T16.54e-7-2.330Likely Benign0.073Likely BenignLikely Benign0.088Likely Benign-0.30Neutral0.770Possibly Damaging0.404Benign2.77Benign0.10Tolerated3.775-110.8-10.04
c.2210A>CQ737PLikely BenignUncertain 1-2.407Likely Benign0.054Likely BenignLikely Benign0.154Likely Benign-1.22Neutral0.005Benign0.013Benign2.78Benign0.04Affected4.073-101.9-31.01
c.2711T>CM904TLikely BenignUncertain 1-2.721Likely Benign0.668Likely PathogenicLikely Benign0.042Likely Benign-1.15Neutral0.277Benign0.103Benign2.78Benign0.18Tolerated3.775-1-1-2.6-30.09
c.2729G>CG910ALikely BenignUncertain 16-33443281-G-C16.20e-7-3.587Likely Benign0.361AmbiguousLikely Benign0.209Likely Benign-1.43Neutral0.999Probably Damaging0.999Probably Damaging2.78Benign0.10Tolerated3.775102.214.03
c.2858C>AP953QLikely BenignUncertain 1-6.038Likely Benign0.079Likely BenignLikely Benign0.086Likely Benign-0.78Neutral0.058Benign0.015Benign2.78Benign0.29Tolerated3.7750-1-1.931.01
c.3859C>AP1287TLikely BenignUncertain 16-33447907-C-A-3.940Likely Benign0.077Likely BenignLikely Benign0.044Likely Benign-0.22Neutral0.126Benign0.041Benign2.78Benign0.04Affected3.775-100.93.99
c.2699C>TT900MLikely BenignConflicting 26-33443251-C-T148.68e-6-3.852Likely Benign0.176Likely BenignLikely Benign0.015Likely Benign-0.81Neutral0.060Benign0.016Benign2.79Benign0.08Tolerated4.324-1-12.630.09
c.3902C>AP1301HLikely BenignConflicting 26-33451776-C-A53.10e-6-5.756Likely Benign0.104Likely BenignLikely Benign0.232Likely Benign-1.13Neutral0.642Possibly Damaging0.378Benign2.79Benign0.04Affected3.7750-2-1.640.02
c.2710A>GM904VLikely BenignLikely Benign 26-33443262-A-G774.78e-5-2.907Likely Benign0.112Likely BenignLikely Benign0.058Likely Benign-0.33Neutral0.039Benign0.023Benign2.80Benign0.10Tolerated3.775212.3-32.06
c.3902C>GP1301RLikely BenignUncertain 16-33451776-C-G159.30e-6-4.753Likely Benign0.162Likely BenignLikely Benign0.076Likely Benign-1.13Neutral0.077Benign0.059Benign2.81Benign0.10Tolerated3.7750-2-2.959.07
c.1862G>AR621Q
(3D Viewer)
Likely PathogenicGAPLikely Benign 16-33440914-G-A191.18e-5-14.682Likely Pathogenic0.910Likely PathogenicAmbiguous0.621Likely Pathogenic0.81Ambiguous0.11.13Ambiguous0.97Ambiguous1.35Destabilizing-3.98Deleterious1.000Probably Damaging0.997Probably Damaging2.82Benign0.01Affected3.3735111.0-28.06243.754.30.00.0-0.40.2XXPotentially PathogenicThe guanidinium group of Arg621, located in an α helix (res. Glu617-Asn635), forms a salt bridge with Glu525 in a nearby loop and stacks with Leu635. In the variant simulations, the carboxamide side chain of Gln621, which can act as both a hydrogen bond acceptor and donor, also stacks with Leu635 but can only sporadically hydrogen bond with Glu525.Accordingly, the residue swap could affect the tertiary structure integrity by disrupting the salt bridge formation. Additionally, due to its location at the GAP-Ras interface, the residue swap could impact the complex formation with the GTPase, but this cannot be investigated using solvent-only simulations.
c.3638A>GN1213SLikely BenignCoiled-coilBenign 16-33446630-A-G138.05e-6-4.086Likely Benign0.081Likely BenignLikely Benign0.094Likely Benign-0.56Neutral0.906Possibly Damaging0.551Possibly Damaging2.82Benign0.68Tolerated3.775112.7-27.0310.1016/j.ajhg.2020.11.011
c.3920C>AP1307QLikely BenignUncertain 16-33451794-C-A-4.227Likely Benign0.114Likely BenignLikely Benign0.192Likely Benign-0.88Neutral0.988Probably Damaging0.765Possibly Damaging2.82Benign0.03Affected3.7750-1-1.931.01
c.3920C>TP1307LLikely BenignBenign 16-33451794-C-T116.82e-6-4.044Likely Benign0.144Likely BenignLikely Benign0.292Likely Benign-1.49Neutral0.779Possibly Damaging0.220Benign2.82Benign0.04Affected3.775-3-35.416.04
c.2277G>AM759ILikely BenignUncertain 16-33441742-G-A16.20e-7-4.058Likely Benign0.393AmbiguousLikely Benign0.075Likely Benign-0.88Neutral0.454Possibly Damaging0.192Benign2.83Benign0.34Tolerated3.995122.6-18.03
c.2275A>CM759LLikely BenignUncertain 16-33441740-A-C21.24e-6-2.431Likely Benign0.093Likely BenignLikely Benign0.048Likely Benign-0.53Neutral0.002Benign0.005Benign2.84Benign1.00Tolerated3.995421.9-18.03
c.3907G>AG1303SLikely BenignUncertain 1-2.271Likely Benign0.125Likely BenignLikely Benign0.155Likely Benign-0.19Neutral0.649Possibly Damaging0.433Benign2.84Benign0.18Tolerated10-0.430.03
c.1991T>CL664S
(3D Viewer)
Likely PathogenicGAPLikely Benign 16-33441250-T-C16.20e-7-16.498Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.543Likely Pathogenic3.75Destabilizing0.23.63Destabilizing3.69Destabilizing2.77Destabilizing-5.99Deleterious1.000Probably Damaging0.996Probably Damaging2.85Benign0.00Affected3.3828-3-2-4.6-26.08215.550.10.00.0-0.20.2XPotentially BenignThe iso-butyl side chain of L664, located on an α-helix (res. Ser641-Glu666), hydrophobically interacts with residues in the inter-helix space between three helices (res. Glu617-Asn635, res. Glu582-Met603, and res. Ser641-Glu666), such as Ile589, Phe663, and Met660. In the variant simulations, the hydroxyl group of Ser664 forms hydrogen bonds with the backbone carbonyl oxygen of another helix residue, such as Met660 or Gln661. This interaction is known to destabilize hydrogen bonding in the α-helix, but this effect was not observed in the simulations. Additionally, Ser664 occasionally forms hydrogen bonds with the carboxylate group of Asp586 on another α-helix (res. Glu582-Met603), which could minimally influence the tertiary structure assembly. Despite these interactions, no major negative effects on the protein structure were observed during the simulations.
c.1925A>CK642T
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-12.823Likely Pathogenic0.948Likely PathogenicAmbiguous0.484Likely Benign0.53Ambiguous0.10.30Likely Benign0.42Likely Benign0.28Likely Benign-5.88Deleterious0.872Possibly Damaging0.839Possibly Damaging2.86Benign0.00Affected3.37310-13.2-27.07213.5-8.7-0.30.40.30.2XUncertainThe amino side chain of Lys642, located on the surface of an α helix (res. Ser641-Glu666), is not involved in any interactions in the WT simulations. In the variant simulations, the shorter side chain of Thr642 forms hydrogen bonds with Glu643 and Thr640 on the same α helix.Regardless, Lys642 is positioned directly at the GAP-Ras interface, and in the SynGAP-Ras WT simulations, its amino side chain forms salt bridges with the carboxylate groups of Ras residues Asp33 and Asp38. The shorter Thr642 is more likely to prefer hydrogen bonding with Glu643 and Thr640 on the same α helix, even in the Ras complex. Thus, the effect of the residue swap on the complex formation with the GTPase cannot be explored using solvent-only simulations.
c.373C>TP125SLikely BenignUncertain 1-3.769Likely Benign0.238Likely BenignLikely Benign0.121Likely Benign-3.57Deleterious0.580Possibly Damaging0.140Benign2.86Benign0.02Affected3.6151-10.8-10.04
c.2349G>AM783ILikely BenignBenign 16-33442901-G-A63.72e-6-3.560Likely Benign0.418AmbiguousLikely Benign0.042Likely Benign-0.54Neutral0.004Benign0.006Benign2.87Benign0.22Tolerated3.646122.6-18.03
c.2860C>TP954SLikely BenignLikely Benign 16-33443412-C-T16.20e-7-3.525Likely Benign0.062Likely BenignLikely Benign0.143Likely Benign-0.25Neutral0.954Possibly Damaging0.812Possibly Damaging2.87Benign1.00Tolerated3.7751-10.8-10.04
c.1540A>TI514F
(3D Viewer)
Likely PathogenicGAPUncertain 1-13.383Likely Pathogenic0.962Likely PathogenicLikely Pathogenic0.601Likely Pathogenic2.35Destabilizing0.33.74Destabilizing3.05Destabilizing0.93Ambiguous-3.98Deleterious0.997Probably Damaging0.993Probably Damaging2.89Benign0.00Affected3.373501-1.734.02
c.2343G>AM781ILikely BenignBenign 1-2.484Likely Benign0.323Likely BenignLikely Benign0.101Likely Benign0.05Neutral0.000Benign0.001Benign2.89Benign1.00Tolerated3.646122.6-18.03
c.2434C>TP812SLikely BenignSH3-binding motifUncertain 16-33442986-C-T16.20e-7-5.689Likely Benign0.456AmbiguousLikely Benign0.162Likely Benign-0.62Neutral0.999Probably Damaging0.966Probably Damaging2.89Benign0.95Tolerated4.3241-10.8-10.04
c.1292T>CL431P
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-14.222Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.659Likely Pathogenic6.78Destabilizing0.311.59Destabilizing9.19Destabilizing2.29Destabilizing-6.39Deleterious1.000Probably Damaging0.998Probably Damaging2.91Benign0.05Affected3.3729-3-3-5.4-16.04222.462.80.10.00.10.0XPotentially PathogenicThe iso-butyl side chain of Leu431, located in an α helix (res. Met414-Glu436), packs against other hydrophobic residues in an interhelix space (e.g., Val434, Leu435, Leu696, Leu711) in the WT simulations. While the backbone amide group of Leu431 forms an H-bond with the carbonyl group of His427, the cyclic five-membered pyrrolidine ring of Pro431, lacking the necessary amide group, cannot do the same. Thus, although the cyclic five-membered pyrrolidine ring of Pro431 packs almost as favorably as the side chain of Leu431 in the hydrophobic niche, the residue swap causes the α helix to partially unfold in the variant simulations.
c.2221C>TP741SLikely BenignUncertain 26-33441686-C-T31.86e-6-3.700Likely Benign0.063Likely BenignLikely Benign0.076Likely Benign-0.27Neutral0.270Benign0.136Benign2.92Benign0.00Affected4.3221-10.8-10.0410.1016/j.ajhg.2020.11.011
c.2350G>AA784TLikely BenignBenign 1-3.579Likely Benign0.089Likely BenignLikely Benign0.046Likely Benign1.23Neutral0.001Benign0.006Benign2.92Benign1.00Tolerated3.64610-2.530.03
c.2420A>TY807FLikely BenignSH3-binding motifUncertain 1-3.667Likely Benign0.073Likely BenignLikely Benign0.057Likely Benign0.14Neutral0.012Benign0.022Benign2.92Benign0.98Tolerated3.775734.1-16.00
c.3995C>TT1332MLikely Benign 16-33451869-C-T201.86e-5-4.107Likely Benign0.948Likely PathogenicAmbiguous0.252Likely Benign-3.63Deleterious1.000Probably Damaging0.991Probably Damaging2.95Benign0.00Affected3.775-1-12.630.09
c.3858A>TE1286DLikely BenignConflicting 46-33447906-A-T1439.22e-5-4.010Likely Benign0.081Likely BenignLikely Benign0.036Likely Benign1.02Neutral0.001Benign0.004Benign2.96Benign1.00Tolerated3.775320.0-14.0310.1016/j.ajhg.2020.11.011
c.3929C>TT1310MLikely BenignBenign 16-33451803-C-T171.05e-5-4.822Likely Benign0.117Likely BenignLikely Benign0.069Likely Benign2.19Neutral0.021Benign0.005Benign2.98Benign0.93Tolerated3.775-1-12.630.09
c.1474A>GK492E
(3D Viewer)
Likely PathogenicGAPConflicting 2-16.175Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.510Likely Pathogenic1.53Ambiguous0.11.90Ambiguous1.72Ambiguous1.42Destabilizing-3.98Deleterious1.000Probably Damaging0.998Probably Damaging2.99Benign0.01Affected3.3735100.40.94
c.2087T>CL696P
(3D Viewer)
Likely PathogenicGAPLikely Pathogenic 1-16.926Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.678Likely Pathogenic6.66Destabilizing0.210.84Destabilizing8.75Destabilizing2.13Destabilizing-6.58Deleterious1.000Probably Damaging1.000Probably Damaging3.00Benign0.00Affected3.4613-3-3-5.4-16.04180.665.90.10.0-0.60.1XPotentially PathogenicThe isobutyl side chain of Leu696, located in the middle of an α-helix (res. Leu685-Gln702), engages in hydrophobic packing with nearby residues (e.g., Leu441, Leu431, Leu692, Leu714) in the inter-helix space. Prolines lack a free amide group necessary for hydrogen bonding with the carbonyl group of Leu692 in the same manner as Leu696 in the WT. Consequently, the residue swap with proline disrupts the continuity of the secondary structure element in the variant simulations. Additionally, the side chain of Pro696 is not as optimal as Leu696 for hydrophobic packing in the inter-helix space.
c.1877T>CI626TLikely PathogenicGAPUncertain 1-10.420Likely Pathogenic0.946Likely PathogenicAmbiguous0.640Likely Pathogenic2.94Destabilizing0.12.70Destabilizing2.82Destabilizing2.23Destabilizing-4.18Deleterious1.000Probably Damaging1.000Probably Damaging3.04Benign0.00Affected0-1-5.2-12.05
c.2075T>AL692Q
(3D Viewer)
Likely PathogenicGAPPathogenic 1-13.873Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.596Likely Pathogenic3.24Destabilizing0.13.27Destabilizing3.26Destabilizing2.76Destabilizing-5.98Deleterious1.000Probably Damaging0.998Probably Damaging3.06Benign0.00Affected3.4217-2-2-7.314.97
c.1904A>GN635S
(3D Viewer)
GAPConflicting 46-33440956-A-G106.20e-6-9.002Likely Pathogenic0.101Likely BenignLikely Benign0.104Likely Benign0.80Ambiguous0.10.67Ambiguous0.74Ambiguous0.95Ambiguous-4.45Deleterious0.261Benign0.044Benign3.06Benign0.05Affected3.3734112.7-27.03196.030.90.10.0-0.30.2XUncertainIn the WT simulations, the carboxamide side chain of Asn635, located on the outer surface of an α helix (res. Glu617-Asn635), forms hydrogen bonds with Gln631 on the same α helix and with the hydroxyl side chain of Ser590 on an opposing α helix (res. Glu582-Met603).In the variant simulations, the side chain of Ser635 is shorter than asparagine and thus prefers to hydrogen bond with the carbonyl group of Gln631 on the same helix and, to a lesser extent, with Ser590 compared to Asn635 in the WT. Ser635 forms hydrogen bonds with the backbone atoms of the same helix, which may destabilize the helix, although this is not clearly evident in the simulations. The weakening of the hydrogen bond between Ser635 and Ser590 in the variant may also weaken the tertiary structure assembly between the helices.Additionally, Asn635 is at the GTPase interface. However, the implication of the residue swap on the complex formation with the GTPase cannot be investigated using solvent-only simulations.

Found 757 rows. Show 200 rows per page. Page 2/4 |